FilingFirehose · free AI preview
HERON THERAPEUTICS, INC. /DE/
HRTX · AI-generated SEC analysis preview · refreshes when data changes
Over the last 90 days, Heron Therapeutics (HRTX) has reported zero cyber incidents and zero red-flag 8-K filings—no bankruptcies, restatements, or officer departures detected in our window. However, low event count in a short timeframe does not indicate low overall risk; the full Report pulls 12 months of filing history, calculates dilution risk scores, maps financing events, and surfaces AI-detected signals that routine screening misses. The full $49 Report adds quantified dilution exposure, contextualized 8-K history, capitalization trends, and early-warning signals across a complete fiscal year.
Want the full 5-section $49 Report on HRTX?
Dilution risk score · 12 months of 8-K context · financing history · AI risk signals · bottom-line framing. Delivered in ~5 minutes.
See a real sample report →
This preview was AI-generated from FilingFirehose's SEC EDGAR ingestion pipeline.
Not investment advice. Verify all claims against original filings.